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Background: Patients with elevated calcium concentrations have an increased morbidity due to various underlying
illnesses. However, there is a lack of studies of quality of life and health care consumption in patients with
hypercalcaemia per se. The study aims to investigate quality of life and health care consumption, as measured by,
sick leave, drug prescriptions and the number of visits and admissions to health care centres and hospitals, in
primary care patients with elevated calcium concentrations.
Methods: A prospective, case control, study in primary care centre, in Sweden. Patients with elevated, (n = 127,
28 men), and normal calcium concentrations, (n = 254, 56 men), mean age 61.4 year, were recruited in the study
and followed during 10 years. Eighty-six percent of those alive at the time of follow up participated in a follow up
visit. The study participants completed a quality of life survey, SF-36, which also were compared with the Swedish
SF-36 national normative database.
Results: Patients with elevated calcium concentrations had significantly lower quality of life both compared with
the control group (patients with normal calcium concentrations) and compared with age and gender-matched
reference material from the Swedish SF-36 national normative database. The group with elevated calcium
concentrations had significantly more hospitalisations (p = 0.017), subsequently cancer diagnoses (p < 0.003), sick
leave (p = 0.007) and medication (p = 0.002) compared with patients with normal calcium concentrations. Men
with elevated calcium concentrations had more contacts with the psychosocial team (p = 0.02) at the health care
centre.
Conclusions: Elevated calcium concentrations are associated with significantly reduced quality of life and increased
health care consumption and should therefore be an important warning flag that should alert the physician to
further investigate and care for the patient. This is the first study in this field and the results need to be confirmed
in further studies.
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Calcium analysis, in plasma or serum, has been used in
primary care for a long time in the screening for primary
hyperparathyroidism, (pHPT), and malignant diseases.
Screening is useful since symptoms are insidious and pa-
tients with increased calcium concentrations do not al-
ways realise that their symptoms can be a sign of disease,
such as pHPT [1]. When point of care analyses of cal-
cium were introduced in primary health care centres,
(PHCCs) some decades ago the number of analyses in-
creased [2]. From previous studies it is known that cal-
cium concentrations in primary care patients are often
just moderately elevated [2]. We have previously shown
that at least 88% of patients with elevated calcium con-
centrations to have an underlying disorder [2].
The most common cause of elevated calcium concen-
tration in primary care is pHPT. The increased calcium
screening has resulted in that pHPT patients are diag-
nosed earlier, when they have milder disease The clinical
picture of pHPT, has therefore changed during recent
years from critically ill patients to patients with subtle
symptoms such as depressed mood, confusion, fatigue,
sleep disorders, neuromuscular symptoms or less obvious
symptoms mainly diagnosed in primary care [3-5]. How-
ever, the severity of psychiatric symptoms is not linearly
related to the degree of hypercalcaemia [6]. pHPT pa-
tients experience a reduced quality of life, QoL, [7,8]. A
Swedish screening study showed that women with a
formerly unknown mild form of pHPT visited physicians
more often and had increased sick leave in the years prior
to the diagnosis [9,10]. More recently, an increased total
mortality from cardiovascular disease [11] and cancer [2]
has been found in men with hypercalcaemia. However,
there is a lack of studies of QoL in patients with hyper-
calcaemia per se, and it is unknown how this is reflected
in health care consumption for this group of patients.
The primary objective of this study was to investigate
QoL in adult patients with elevated calcium concentra-
tions, in order to provide guidance to further manage-
ment in primary care. The secondary objective was to
study whether elevated calcium concentrations affect
health care consumption, as measured by sick leave,
drug prescriptions and the number of visits and admis-
sions to health care centres and hospitals.
Methods
Subjects
Tibro is a rural community in Sweden with 11,000 inhabi-
tants and one PHCC. Medical records of all patients with
elevated calcium concentrations between 1995–2000
have been studied previously [12], Figure 1. At baseline,
1995–2000, an elevated calcium concentration was de-
fined as ≥2.56 mmol/l in at least one test. Calcium was
corrected for albumin in 75% of patients who had takenit in conjunction with the calcium sampling. Two age
and sex-matched controls with calcium < 2.45 mmol/l
were selected for each patient from the PHCCs elec-
tronic data. Age was matched within 2 months, but for
the oldest (n = 2), the match was within three years.
Individuals with borderline calcium concentrations, be-
tween 2.45- 2.55 mmol/L, were excluded to avoid values
difficult to interpret. For 45 patients there was only an
initial single high calcium concentration. The majority of
these samples were analysed between January 1997 to
April 1998, when quality controls revealed that the ana-
lyses deviated above defined quality levels [2]. At follow
up these patients had no underlying diagnoses and were
therefore excluded from the analyses, Figure 1.
For all patients, data regarding visits to general practi-
tioner and psychosocial team between 1st January 1998
and 8th December 2010 and certified sick leave between
4th November 2003 and 27th December 2010 was col-
lected from their health care medical records (ProfDoc
Journal III, ProfDoc AB). Diagnoses and durations of all in-
patient care between 1st January 1967 and 31st December
2010 were derived from The Swedish National Board of
Health and Welfare. The different time intervals were due
to variation of registration in the registries.
All study subjects alive at the time of follow up in July
2011 were invited by mail to participate. The participa-
tion rate was 86%. Non-responders were contacted by
telephone. A nurse interviewed all the participants about
their diseases and self-reported current medication was
recorded. Non-fasting blood samples were drawn, cal-
cium, ionised calcium and intact parathyroid hormone
were measured as previously described [2]. Subjects who
had moved were interviewed by phone and blood sam-
ples were taken at their local PHCC. The ethics commit-
tee at Regional Ethical Review Board at Gothenburg
University, (696–07) approved the study in 2008.Consent
Written informed consent was obtained from the pa-
tients for the publication of this report.Quality of life assessments
The study participants completed the QoL health survey
SF-36 [13], a health status measurement that allows com-
parison of the burden of illness. SF-36 is applicable regard-
less of patient condition and has been validated in a variety
of diseases [14]. The survey has 36 simple questions, which
are scored and aggregated. The survey defines eight separ-
ate and distinct areas or domains of health status: physical
functioning, physical role functioning, bodily pain, general
health, vitality, social role functioning, emotional role func-
tioning and mental health, Figure 2. The number of ques-
tions that contributes to each domain ranges from 2 to 10.
Figure 1 Included patients and variables. Flow chart of drop-outs and included variables among patients with elevated and normal calcium
concentrations at Tibro Health Care Centre, Sweden, first investigation1995–2000, and re-examination 2009–2010.
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indicating better QoL.
Data from both comparison groups (patients with ele-
vated calcium concentrations and patients with normal
calcium concentrations) were compared with an age and
gender-matched reference material (in average 2.3 individ-
uals) from Sweden (n = 703) in the Swedish SF-36 nationalnormative database [15]. We used 20-years intervals, (20–
39, 40–59, 60–79, and 80–99 years) in the analyses.
Statistics
Descriptive patient statistics were presented and compari-
sons were performed using the T-test, the Chi2-test and the
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Figure 2 Results of quality of life in the SF-36 survey. Quality of life studied with SF-36 survey in patients with raised and normal calcium
concentrations at Tibro Health Care Centre, Sweden. Higher scores indicate better quality of life.
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analysed with non parametric test, substantially Mann–
Whitney. A p-value < 0.05 was considered statistically signifi-
cant. Data are given as mean ± SD in Figure 2 and as mean,
10th and 90th percentile in Tables 1 and 2. All statistical ana-
lyses were performed using the SPSS 20 statistical package.Results
Characteristics
Characteristics of patients with elevated and normal cal-
cium concentrations are given in Table 1. The patients
with elevated calcium concentrations at baseline had
normalised calcium concentrations at the time of the
follow up, however, still higher than in the group of pa-
tients with normal calcium concentrations at base-line,
Table 1. The two groups demonstrated similar values in
the upper reference range of parathyroid hormone.
There was no difference in marital status, level of edu-
cation, or employment, number of smokers between pa-
tients with elevated and normal calcium concentrations
(data not shown).Quality of life
The group with elevated calcium concentration had lower
scores in all SF-36 domains compared with the group with
normal calcium concentration, Figure 2. In five domains
the scores were at least 10 points lower in the group with
elevated calcium concentrations compared with the pa-
tients with normal calcium concentrations, Figure 2. The
differences were significant in all domains, except emo-
tional functioning, Figure 2. Compared with the Swedish
norm group patients with elevated calcium concentrationshad significantly lower scores in all SF-36 survey domains
except bodily pain.
Health care consumption
At the time of follow up in July 2011 only 21 of the patients
with elevated calcium concentrations were of working age,
the rest had retired or died. For the overall group there
were significantly more days in inpatient care compared
with the normal calcium group, Table 2. Looking at the
subpopulation of men, the difference was not significant,
although numerically the group with elevated calcium con-
centrations had twice as many hospital days and care occa-
sions as the group with normal calcium concentrations.
Patients with elevated calcium concentrations had signifi-
cantly more cancer diagnoses associated with hospitalisa-
tion than patients with normal calcium concentrations. We
could not find any differences between the groups in num-
ber of visits to the PHCC physician; however, men with ele-
vated calcium concentrations had more contacts with the
psychosocial team, Table 2.
Overall patients with elevated calcium concentrations
had significantly more sick leave and drug treatment,
compared with patients with normal calcium concentra-
tions, Table 3.
Discussion
To our knowledge this is the first study showing that pa-
tients in primary care with elevated calcium concentra-
tions per se have significantly reduced QoL compared
with patients with normal calcium concentrations and
more pronounced reduction compared with the Swedish
norm population. They had significantly more contacts
with the psychosocial team, more sick leaves, more
Table 1 Characteristics of patients with elevated and normal calcium concentrations 1995–2000 and 2008–2010, men and women, at Tibro Health Care
Centre, Sweden
Patients with elevated calcium
concentrations










Variables Mean Percentile Mean Percentile Mean Percentile Mean Percentile Mean Percentile Mean Percentile
Data from register 1995–2000
Number 127 28 99 254 56 198
Age, January 1st 1995 61.4 36.6- 80.0 55.6 31.8- 77.0 63.0 38.8- 80.2 61.3 36.3- 80.0 55.5 39.0- 80.3 62.9 31.0- 77.0 n.s n.s n.s
Age, range 18–94 18–82 18–94 18–91 18–82 18–91
S- Calcium1 2.66 2.56- 2.78 2.72 2.57- 2.88 2.64 2.56- 2.78 2.33 2.21- 2.43 2.31 2.19- 2.42 2.33 2.21- 2.44 <0.001 <0.001 <0.001
Data from clinical investigation 2008–2010
Number 63 12 51 133 33 100
Age, January 1st 2011 71.4 49.4- 89.0 67.7 49.2- 80.0 72.3 52.0- 89.0 70.0 45.2- 88.0 66.8 45.2- 84.4 71.0 45.8- 90.0 n.s n.s n.s
Age, range 31–97 45–82 31–97 30–99 31–99 30–97
P- Calcium2 2.42 2.26- 2.59 2.39 2.18- 2.55 2.43 2.27- 2.64 2.35 2.22- 2.47 2.32 2.21- 2.42 2.36 2.23- 2.48 <0.001 0.085 0.003
Ionised Calcium3 1.29 1.22- 1.40 1.28 1.24- 1.31 1.29 1.22- 1.44 1.23 1.18- 1.27 1.22 1.16- 1.26 1.23 1.18- 1.28 <0.001 <0.001 <0.001
Parathyroid hormone4 68 20- 118 60 14- 136 69 21- 113 58 26- 107 57 22- 104 59 28- 113 n.s n.s n.s
Notes: Data are means (SD), n.s = not significant, Age in years. Reference range 1Serum Calcium analysed in whole blood (mmol/L) 2.15–2.55 (mmol/L), 2Plasma Calcium (mmol/L) 2.15–2.50, 3Ionised Calcium (mmol/L)





















Table 2 Hospitalisation of patients between 1st January 1967 and 31st December 2010 and contacts with Tibro Health Care Centre Sweden between 1st
January 1998 and 31st December 2010 by patients with elevated and normal calcium concentrations 1995–2000, men and women
Patients with elevated calcium
concentrations
Patients with normal calcium
concentrations
Comparison between groups






Variables Mean Percentile Mean Percentile Mean Percentile Mean Percentile Mean Percentile Mean Percentile
Data from register
Number 127 28 99 254 56 198
Hospitalisation
Total occasion from 1967 11 2-21 14 2-33 10 2-20 8 2-18 7 1-14 9 2-19 0.017 0.002 n.s
Total days from 1967 75 6-179 82 4-214 73 7-178 58 4-146 39 3-98 63 6-161 n.s 0.006 n.s
Total occasion from 1995 7 2-13 11 2-29 7 1-12 5 1-11 5 1-11 6 1-11 0.029 0.015 n.s
Total days from 1995 51 3-128 61 4-154 48 2-128 37 3-77 26 3-63 41 3-79 n.s 0.018 n.s
Diagnoses per individual from 1968
Cancer 1.3 0-4 1.7 0-6.3 1.2 0-3 0.9 0-2.2 0.8 0-3.6 1 0-2 0.003 n.s 0.017
Psychiatric diseases 0.9 0-2 0.7 0-2.3 0.9 0-2 0.5 0-1 0.3 0-1.6 0.5 0-1 n.s n.s n.s
Cardiovascular diseases 3.0 0-9 4.8 0-16 2.5 0-7 2.4 0-6 2.3 0-8 2.4 0-6 n.s n.s n.s
Contact tibro HCC
Physician consultations
Per individual 18.0 3.0- 35.4 12.5 2.6- 24.6 19.6 2.6- 39.0 17.7 4.0- 37.5 16.0 4.0- 31.0 18.2 3.5- 38.0 n.s n.s n.s
Individuals visit psychosocial team
Number 13 4 9 14 1 13 n.s 0.02 n.s.





















Table 3 Sick leave between 4th November 2003 and 27th December 2010 and medication of patients with elevated
and normal calcium concentrations 1995–2000 at Tibro Health Care Centre, Sweden
Patients with elevated calcium
concentrations
Patients with normal calcium
concentrations
Comparison between the groups




Individuals with certificates 12 25 0.90
Certificates/individual (n) 7.5 6.5 5.2 2.0 0.02
Days/individual 258 144 120 22 0.007
Days/certificate 34 28 23 17 < 0.001
Days/sick leave episode 87 47 54 15 0.001
Data from clinical investigation
Medication
All 63 5.3 5.0 132 3.5 3.0 0.002
n.s = not significant.
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normal calcium concentrations.Quality of life
In many of the domains in the SF-36 health survey the
group with elevated calcium concentrations had more
than 10 points lower results compared with the Swedish
norm. This magnitude of difference has probably a clin-
ical significance at group level [2].
It may seem counter-intuitive that the QoL according
to SF-36 survey showed a significant difference between
the two groups despite the fact that the mean calcium
concentration in the group with elevated calcium con-
centration at baseline had normalised at the time of fol-
low up. However, the highest calcium values at baseline
were found among those who died during the observa-
tion period, and almost half of the 46 patients with pHPT
had undergone parathyroidectomy (and in most cases be-
came normocalcaemic after surgery) [2]. This contributes
to the decline of calcium concentrations at group level.
It is also reasonable to assume that patients who did
not participate in the follow up may be in the poorer
spectrum of health, one third of the drop-outs reported
disease as a reason not to participate in the follow up.
Our interpretation is that the differences found in the
SF-36 scores may in fact underestimate the QoL in
hypercalcaemic patients.
There were no significant difference in PTH values
between patients with elevated and normal calcium
concentration. We believe that the 20 patients that had
undergone parathyroidectomy contribute to the de-
cline in PTH levels in the group with elevated calcium
concentrations.Health care consumption
It is previously known that low scores in the domain gen-
eral health is associated with more doctor calls, more
medication and hospitalisation [16]. This is supported by
our study as we found an increased health care consump-
tion in patients with elevated calcium concentrations.
The subjects eligible for sick leave were few because of
the age distribution in the study, but still, significantly
more certificates and more sick leave days were found in
the group with elevated calcium concentration. This is
in line with a Swedish study of women with unknown,
mild pHPT where an increased sick leave rate was ob-
served in the years before the diagnosis [9,10]. Had it
been possible to compare our material with a Swedish
norm regarding sick leave, we speculate that we may
have seen an even greater difference since our controls
were patients with symptoms that led to ordering of cal-
cium analyses and not healthy controls. Furthermore,
there was a low score in the SF-36 domain physical
functioning, a domain which has previously been shown
to be correlated to a reduced capacity to work [15].
Significantly more individuals were hospitalised with
cancer diagnoses among those with elevated calcium
concentrations. The difference is not significant in the
male subpopulation, probably because of the small num-
bers. In our previous study we found increased mortality
among men, especially in cancer [2]. We could not find
any differences between the groups in number of visits
to the PHCC physicians in line with the Swedish screen-
ing study [9,10]. However men with elevated calcium
concentrations had more contact with the psychosocial
team.
The strength of this study is the high participation
rate, 86% at follow up, probably due to the confinement
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from all of Sweden for several decades means that the
material is comprehensive. This study is unique since
there is no previously published study of hypercalcaemia
per se and QoL.
One limitation of this study was that the inclusion of
the calcium analysis for the patient group was based on
a single calcium concentration measurement which was
corrected for calcium in 75% of cases. This may have led
to that erroneous individuals were included in the study.
Another limitation of this study is that SF-36 data at
baseline is not available for comparison with SF-36 data
at follow up. Another drawback is also that the controls
were selected among patients with various disorders
at the PHCC. An age and sex matched random sample
from the population would have been optimal, but it
was not possible since the study which is the basis for
this prospective study was retrospective. Another limita-
tion is the small study sample as the study was per-
formed in a single PHCC. The results should therefore
be interpreted with caution especially, in the subgroups.
Conclusions
In conclusion, elevated calcium concentrations are associ-
ated with significantly reduced QoL and increased health
care consumption, as measured by, sick leave, drug pre-
scriptions and the number of visits and admissions to
health care centres and hospitals. The clinical consequences
of poor QoL in patients with elevated calcium concentra-
tions include not only suffering for the individual, but also
an increased cost to society in terms of increased health
care consumption. Elevated calcium concentration is there-
fore an important warning flag that should alert the phys-
ician to further investigate and care for the patient.
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